15 Articles
Review Article
Open Access | Apr 12, 2022
Various clinical presentations of uveitis associated with durvalumab treatment
, , , , and
Research Article
Open Access | Mar 28, 2022
Radiomic features as biomarkers of soft tissue paediatric sarcomas: preliminary results of a PET/MR study
, , , , , , and
Open Access | Apr 13, 2022
Image reconstruction using small-voxel size improves small lesion detection for positron emission tomography
, , , , and
Open Access | May 04, 2022
Evaluation of toxic effects of chemotherapy in lung malignancies on cerebral white matter using diffusion tensor imaging
, , , , , , and
Open Access | Apr 13, 2022
Single centre experience with Excluder® stent graft; 17-year outcome
, , and
Open Access | Mar 28, 2022
Sunitinib potentiates the cytotoxic effect of electrochemotherapy in pancreatic carcinoma cells
, , , , and
Open Access | Apr 07, 2022
Expression of DNA-damage response and repair genes after exposure to DNA-damaging agents in isogenic head and neck cells with altered radiosensitivity
, , , , , and
Open Access | Apr 07, 2022
Co-treatment with vactosertib, a novel, orally bioavailable activin receptor-like kinase 5 inhibitor, suppresses radiotherapy-induced epithelial-to-mesenchymal transition, cancer cell stemness, and lung metastasis of breast cancer
, , and
Open Access | Dec 22, 2021
Cervix-Online computer program: 27 years of hospital-based clinical registry for cervical cancer at the University Medical Centre Maribor
, and
Open Access | Dec 22, 2021
Residual disease in lymph nodes has no influence on survival in patients with incidental gallbladder cancer – institution experience with literature review
, , and
Open Access | Mar 28, 2022
Moderate hypofractionated helical tomotherapy for older patients with localized prostate cancer: long-term outcomes of a phase I–II trial
, , , , , , , and
Open Access | Feb 25, 2022
Clinical impact of post-progression survival in patients with locally advanced non-small cell lung cancer after chemoradiotherapy
, , , , , , , and
Open Access | May 17, 2022
Ribociclib plus letrozole in patients with hormone receptor-positive, HER2-negative advanced breast cancer with no prior endocrine therapy: subgroup safety analysis from the phase 3b CompLEEment-1 trial
, , , , , , , and
Open Access | May 17, 2022
The dose accumulation and the impact of deformable image registration on dose reporting parameters in a moving patient undergoing proton radiotherapy
, , and
Open Access | Mar 28, 2022
Does CyberKnife improve dose distribution versus IMRT and VMAT on a linear accelerator in low-risk prostate cancer?
, , and
Search
All Volumes and Issues in this Journal
Volume 58 (2024)